|
Shalev, O; Hileti, D; Nortey, P et al. (1999) Transport of 14C-deferiprone in normal, thalassaemic and sickle red blood cells. Br J Haematol 105:1081-3
|
|
Browne, P; Shalev, O; Hebbel, R P (1998) The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med 24:1040-8
|
|
Sheng, K; Shariff, M; Hebbel, R P (1998) Comparative oxidation of hemoglobins A and S. Blood 91:3467-70
|
|
Cragg, L; Hebbel, R P; Miller, W et al. (1998) The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells. Blood 92:632-8
|
|
Shalev, O; Hebbel, R P (1996) Extremely high avidity association of Fe(III) with the sickle red cell membrane. Blood 88:349-52
|
|
Shalev, O; Hebbel, R P (1996) Catalysis of soluble hemoglobin oxidation by free iron on sickle red cell membranes. Blood 87:3948-52
|
|
Enright, H; Miller, W J; Hays, R et al. (1996) Preferential targeting of oxidative base damage to internucleosomal DNA. Carcinogenesis 17:1175-7
|
|
Browne, P V; Mosher, D F; Steinberg, M H et al. (1996) Disturbance of plasma and platelet thrombospondin levels in sickle cell disease. Am J Hematol 51:296-301
|
|
Shalev, O; Repka, T; Goldfarb, A et al. (1995) Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood 86:2008-13
|
|
Sugihara, T; Yawata, Y; Hebbel, R P (1994) Deformation of swollen erythrocytes provides a model of sickling-induced leak pathways, including a novel bromide-sensitive component. Blood 83:2684-91
|
Showing the most recent 10 out of 22 publications
